Technical Analysis for TGTX - TG Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 9.05 1.12% 0.10
TGTX closed up 1.12 percent on Thursday, September 20, 2018, on 1.37 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical TGTX trend table...

Date Alert Name Type % Chg
Sep 20 Calm After Storm Range Contraction 0.00%
Sep 20 Doji - Bullish? Reversal 0.00%
Sep 20 Lower Bollinger Band Walk Weakness 0.00%
Sep 20 Wide Bands Range Expansion 0.00%
Sep 20 Lower Bollinger Band Touch Weakness 0.00%
Sep 20 Oversold Stochastic Weakness 0.00%
Sep 19 Calm After Storm Range Contraction 1.12%
Sep 19 NR7 Range Contraction 1.12%
Sep 19 Lower Bollinger Band Walk Weakness 1.12%
Sep 19 Inside Day Range Contraction 1.12%

Older signals for TGTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
TG Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The company is developing two advanced therapies targeting hematological malignancies. The TGTX-1101 (ublituximab) is a novel, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes, which is in clinical development for patients with relapsed and refractory non-Hodgkin's lymphoma. The TGR-1202 is an orally available PI3K delta inhibitor believed to be important in the proliferation and survival of B-lymphocytes. TG Therapeutics, Inc. is headquartered in New York, New York.
Is TGTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.35
52 Week Low 7.25
Average Volume 1,098,868
200-Day Moving Average 12.4432
50-Day Moving Average 11.6975
20-Day Moving Average 11.4288
10-Day Moving Average 10.4075
Average True Range 0.6453
ADX 34.72
+DI 5.7798
-DI 35.7436
Chandelier Exit (Long, 3 ATRs ) 10.9641
Chandelier Exit (Short, 3 ATRs ) 10.5359
Upper Bollinger Band 14.0037
Lower Bollinger Band 8.8539
Percent B (%b) 0.04
BandWidth 45.059849
MACD Line -0.7508
MACD Signal Line -0.4157
MACD Histogram -0.3351
Fundamentals Value
Market Cap 563.91 Million
Num Shares 62.3 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -4.64
Price-to-Sales 3189.49
Price-to-Book 6.24
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.95
Resistance 3 (R3) 9.90 9.55 9.80
Resistance 2 (R2) 9.55 9.32 9.58 9.75
Resistance 1 (R1) 9.30 9.18 9.43 9.35 9.70
Pivot Point 8.95 8.95 9.01 8.98 8.95
Support 1 (S1) 8.70 8.72 8.83 8.75 8.40
Support 2 (S2) 8.35 8.58 8.38 8.35
Support 3 (S3) 8.10 8.35 8.30
Support 4 (S4) 8.15